Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen et al. · New England Journal of Medicine · 2009 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

Michael Henke, Roland Laszig, Christian Rübe et al. · The Lancet · 2003 · 1.3K citations

Medicine, Oncology, Radiation Oncology +11

Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin

Toshio Kitamura, Tsuyoshi Tange, Takashi Terasawa et al. · Journal of Cellular Physiology · 1989 · 825 citations

Life Sciences, Cell Biology, Hematology +13

Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

Michael Brines, Giovanni Grasso, Fabio Fiordaliso et al. · Proceedings of the National Academy of Sciences · 2004 · 653 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation

Oded Livnah, E.A. Stura, Steven A. Middleton et al. · Science · 1999 · 598 citations

Life Sciences, Biochemistry, Molecular Biology +17